PERRIGO Co plc
Close on Oct 19, 2026
- Market cap
- $2.25B
- P/E (TTM)
- –
- Dividend yield
- 7.21%
About Perrigo
Pharmaceutical Preparations, SIC 2834
Perrigo Company plc provides over-the-counter self-care, health, and wellness products. The company operates through two business segments: Consumer Self-Care Americas and Consumer Self-Care International. Its product portfolio spans upper respiratory remedies, infant nutrition, digestive health, pain and sleep aids, oral hygiene, skincare, women's health, and dietary supplements. Perrigo produces retailer store brands as well as proprietary branded goods. Its customers include retail pharmacies, supermarkets, mass merchants, wholesalers, and e-commerce platforms, with Walmart serving as its largest individual customer.
The company employs roughly 8,100 people across 31 countries and markets products in more than 30 countries, predominantly in North America and Europe. Its primary manufacturing operations reside in the United States, supplemented by production facilities in the United Kingdom, Belgium, France, Germany, and China, as well as distribution hubs across the United States, Europe, and Australia. Perrigo is incorporated under Irish law, while a specific headquarters location is not identified in the text.
Summary of the business section of Perrigo's latest annual report, written by StockData.
Company profile
Company
- Legal name
- PERRIGO Co plc
- Founded
- 1887
- Headquarters
- Dublin 2, L2
- Address
- The Sharp Building, Hogan Place D02 TY74
- Phone
- (269) 673-8451
- Website
- perrigo.com
- Employees
- 8,100, Dec 31, 2025
- Industry
- Pharmaceutical Preparations
- Incorporated in
- L2
- Fiscal year ends
- December 31
- Auditor
- Ernst & Young LLP, Grand Rapids, Michigan
Stock & identifiers
- Ticker
- PRGO
- Exchange
- NYSE
- IPO date
- Dec 17, 1991
- Shares outstanding
- 139M, Jul 31, 2026
- Public float
- $3.65B, Jun 27, 2025
- Filer category
- Large accelerated filer
- Stock splits
- 2-for-1, Aug 26, 1993
- SEC CIK
- 1585364
- CUSIP
- G97822103
- ISIN
- USG978221038
- LEI
- 549300IFOQS6R1QLY196
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Albert Manzone | Interim President and CEO, Director | 16,353 |
| David Ball | EVP & CBDO | 11,664 |
| Eduardo Guarita Bezerra | EVP & Chief Financial Officer | 84,700 |
| Roberto Khoury | EVP and President of CSCI | 14,113 |
| Matthew John Winterman | EVP, Supply, Ops, Strategy | 8,365 |
| Charles Atkinson | EVP, General Counsel & Sec. | 5,855 |
| Abigail Lennox | EVP and CSO | 4,607 |
| Robert Willis | EVP & CHRO | 50,568 |
| Triona Schmelter | EVP & President CSCA | 6,670 |
| Ronald Craig Janish | EVP, Gbl Ops & SC & CTO | 40,574 |
| Bradley A. Alford | Director | 46,728 |
| Geoffrey M. Parker | Director | 77,734 |
| Ahmed Salman Amin | Director | 0 |
| Muhammad Omer Gajial | Director | 0 |
| Jonas Samuelson | Director | 1,594 |
| Kevin Francis Egan | Director | 3,798 |
| Orlando D. Ashford | Director | 27,717 |
| Donal O'Connor | Director | 39,140 |
| Julia M. Brown | Director | 15,339 |
| Adriana Karaboutis | Director | 27,629 |
| Jeffrey B. Kindler | Director | 10,559 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 P.Lockwood Taylor | $9.04M | $2.86M | $3.49M | $37 | $141 |
| FY2024 | $7.14M | $4.95M | $2.63M | $65 | $137 |
| FY2024 Current Ceo | $7.14M | $4.95M | $2.63M | $65 | $137 |
| FY2024 Former Ceo | $0 | $0 | $2.63M | $65 | $137 |
| FY2024 P.Lockwood Taylor | $7.14M | $4.95M | $2.63M | $65 | $137 |
| FY2023 Current Ceo | $6.07M | $5.91M | $2.51M | $78 | $119 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“Our global workforce consists of approximately 8,100 full-time and part-time employees spread across 31 countries, of which approximately 17.5% were covered by collective agreements as of December 31, 2025.”
Corporate history
Events identified from SEC filings